CytomX Therapeutics, Inc. CTMX
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Etzer Darout | Barclays | 1.96 $ | 3.5 $ | 1.54 % | 16/09/2025 |
| Matthew Biegler | Oppenheimer | 2.32 $ | 7 $ | 4.68 % | 31/07/2025 |
| Etzer Darout | BMO Capital | 1.09 $ | 3.68 $ | 2.59 % | 08/11/2024 |
| Joseph Catanzaro | Piper Sandler | 1.09 $ | 3.25 $ | 2.16 % | 08/11/2024 |
| Etzer Darout | BMO Capital | 1.18 $ | 3.56 $ | 2.38 % | 09/08/2024 |
| Joseph Catanzaro | Piper Sandler | 1.75 $ | 3.5 $ | 1.75 % | 27/05/2024 |
| Etzer Darout | BMO Capital | 4.19 $ | 3.59 $ | -0.60 % | 09/05/2024 |
| Robert Driscoll | Wedbush | 2.3991 $ | 8 $ | 5.60 % | 09/05/2024 |
| Roger Song | Jefferies | 4.455 $ | 8 $ | 3.55 % | 05/05/2024 |
| Roger Song | Jefferies | 2.15 $ | 2.5 $ | 0.35 % | 12/03/2024 |
| Etzer Darout | BMO Capital | 2.15 $ | 3.25 $ | 1.10 % | 12/03/2024 |